S&P Futures
5,892.50 -4.00 (-0.07%) Dow Futures
43,483.00 -85.00 (-0.20%) Nasdaq Futures
20,511.00 +17.25 (+0.08%) Russell 2000 Futures
2,318.30 +4.70 (+0.20%) Crude Oil
67.26 +0.24 (+0.36%) Gold
2,600.00 +29.90 (+1.16%)
Genetic Technologies Limited (GENE)
| Previous Close | 0.7650 |
| Open | 0.7900 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.7650 - 0.7650 |
| 52 Week Range | 0.6700 - 3.7500 |
| Volume | |
| Avg. Volume | 12,418 |
| Market Cap | 3.708M |
| Beta (5Y Monthly) | 0.48 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | Aug 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREBioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / October 11, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg ...
GlobeNewswireJoin Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2
MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Genetic Technologies’ senior leadership who will share insight into the Company’s portfolio of genomic
